One Drop app predicts blood sugar up to 2 hours in advance

By staff writers

November 18, 2019 -- Digital diabetes therapeutics company One Drop said it has developed an artificial intelligence (AI) application that can predict blood sugar levels up to two hours in advance for people with type 2 diabetes using continuous glucose monitoring (CGM).

The One Drop glucose monitoring app
Image courtesy of One Drop.

Data show that the new model predicted glucose levels within 20% of actual levels in people with type 1 and type 2 diabetes. This information is useful for preventing adverse events associated with a sharp fall or rise in glucose, the company noted.

The two-hour forecasting builds on the company's Predictive Insights eight-hour forecasts released through a smartphone app. Information provided to users draws from AI-driven analyses of health data from more than 1.5 million One Drop users, according to the company. In addition to forecasts about blood glucose, the app offers personalized guidance for correcting levels and helps consumers track their diet and exercise, among other factors affecting their condition.

Self-testing helps drive demand for bustling HbA1c market
Bruce Carlson, publisher of Kalorama Information, explores factors driving the demand for hemoglobin A1c (HbA1c) testing in people with diabetes, including...
Blood test spots diabetes complications early on
A prototype test that uses highly sensitive biomarkers to analyze DNA in blood is able to determine earlier and more accurately if patients with type...
Point-of-care testing tackles diabetes risk in Texas
One of the key advantages of point-of-care (POC) testing is the ability to offer test results within a matter of minutes, instead of several hours or...
More frequent HbA1c testing reduces diabetes costs
Performing hemoglobin A1c (HbA1c) testing four times a year reduces costs and improves quality of life for individuals with diabetes compared to less...
Blood sugar test from GE's Drawbridge clears FDA
Drawbridge Health, a privately held company founded by GE, announced that its OneDraw single-use point-of-care device for testing hemoglobin A1c in people...

Copyright © 2019

Last Updated np 11/18/2019 11:45:06 AM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.